Bionow | News

ITS Wins ISPE UK Affiliate Supplier of the Year Award

Nov 22nd 2024

ITS Ltd is proud to announce that we have been awarded the Supplier of the Year at the ISPE UK Affiliate Annual Award Dinner 2024!

ITS Ltd Announces Ownership Transition as Andrew Mills Acquires Company

Nov 4th 2024

ITS Ltd has announced a significant ownership change. Andrew Mills, the company's Managing Director for the past year, has acquired full ownership of the business and will now serve as Chief...

Myricx Bio announces £90m ($114m) Series A financing to advance its novel NMTi-...

Jul 8th 2024

Myricx Bio, a UK biotech company focusing on the discovery and development of a completely novel class of payloads for antibody-drug conjugates (ADCs), today announced the closing of its Ser...

AstraZeneca, on fast track of growth, sets revenue target at $80B by 2030

May 22nd 2024

In his first decade as CEO at AstraZeneca, Pascal Soriot achieved one ambitious revenue goal. Now he shoots for another, targeting sales of $80 billion for the drugmaker by 2030.

University of Manchester, Boots And No7 beauty company renew 20-year partnership...

Apr 22nd 2024

The pioneering collaboration is delivering game-changing British skincare products and high street success including the launch of No7 Future Renew – the UK’s biggest ever beauty launch

Andy Cowan Appointed as President of Particle Measuring Systems

Mar 16th 2024

Andy Cowan appointed as President of Particle Measuring Systems and he will report to Mark Fleiner, President Spectris Scientific and Malvern Panalytical

AMPLY Discovery raises £1.4m in Innovate UK grant funding to tackle complex dis...

Feb 20th 2024

Belfast-based techbio company AMPLY Discovery Limited has raised over £1.4m in grant funding to develop new drug products using its proprietary AI-driven drug discovery platform.

PharmaKure granted MHRA Clinical Trial Authorisation (CTA) for PK051 for the tre...

Jan 5th 2024

Clinical Trial Authorisation application granted for combined drug PK051 targeting amyloid deposits associated with Alzheimer’s Disease

PharmaKure submits MHRA CTA for Phase 2a Clinical Trial of PK051 in patients wit...

Oct 24th 2023

PharmaKure submits MHRA CTA for Phase 2a Clinical Trial of PK051 in patients with mild cognitive impairment Clinical Trial Application filed for combined drug targeting amyloid deposits as...

Biocair takes home two awards at the prestigious Asia-Pacific Cell & Gene Therap...

Sep 22nd 2023

Biocair, a distinguished life science logistics company with over three decades of expertise, was announced as the winner of two awards at the esteemed Asia-Pacific Cell & Gene Therapy Excel...

Life Sciences Employability Week

Aug 2nd 2023

University of Liverpool Life Sciences Employability Week (w/c 6th November 2023)

PharmaKure and APIS Assay Technologies Sign a Collaboration for the Development ...

Jul 3rd 2023

PharmaKure, a company specialising in companion diagnostics for the treatment of neurological diseases and APIS Assay Technologies Ltd, a company with scientific expertise in biomarker trans...

News